Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OAD Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Large-scale testing (Phase 3)Study completedNCT00912015
What this trial is testing

A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol OAD Tablets to Twice Daily Tramadol BID for the Treatment of Osteoarthritis of the Knee (Extension Protocol) and Open Label Safety Follow-Up

Who this might be right for
PainOsteoarthritis, Knee
Labopharm Inc. 238
Testing effectiveness (Phase 2)Study completedNCT06199505
What this trial is testing

A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM

Who this might be right for
Type 2 Diabetes
Gan and Lee Pharmaceuticals, USA 153
Not applicableStudy completedNCT00665808
What this trial is testing

Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 8,125
Testing effectiveness (Phase 2)Study completedNCT00613951
What this trial is testing

Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 182
Large-scale testing (Phase 3)Study completedNCT00833911
What this trial is testing

An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee

Who this might be right for
Osteoarthritis, Knee
Labopharm Inc. 392
Post-approval studies (Phase 4)Study completedNCT00949442
What this trial is testing

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 708
Large-scale testing (Phase 3)Study completedNCT06871761
What this trial is testing

A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes

Who this might be right for
Adult Patients With Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 393
Testing effectiveness (Phase 2)UnknownNCT05808335
What this trial is testing

Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)

Who this might be right for
Chronic Hepatitis B
ImmuneMed, Inc. 32
Large-scale testing (Phase 3)Study completedNCT03175120
What this trial is testing

A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 453
Large-scale testing (Phase 3)Study completedNCT01676116
What this trial is testing

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 438
Post-approval studies (Phase 4)Study completedNCT00819741
What this trial is testing

Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 433
Post-approval studies (Phase 4)Study completedNCT00605111
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 193
Not applicableStudy completedNCT03092752
What this trial is testing

Clinical Characteristics and Practice Patterns of Type 2 Diabetes Mellitus Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDV

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 162,116
Testing effectiveness (Phase 2)Study completedNCT00614055
What this trial is testing

Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 178
Post-approval studies (Phase 4)Study completedNCT00908921
What this trial is testing

Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 391
Post-approval studies (Phase 4)Study completedNCT06145360
What this trial is testing

Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient

Who this might be right for
Glucose Metabolism DisordersDiabetes Mellitus, Type 2Hypoglycemic Agents+1 more
SINA Health Education and Welfare Trust 150
Post-approval studies (Phase 4)Study completedNCT01238978
What this trial is testing

Phase 4 Study in the Elderly Patients With T2DM

Who this might be right for
Type 2 Diabetes MellitusElderly
Novartis 46
Large-scale testing (Phase 3)Study completedNCT00775203
What this trial is testing

A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.

Who this might be right for
Major Depressive Disorder
Labopharm Inc. 412